Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001

被引:37
作者
Ciesla, G
Leader, S
Stoddard, J
机构
[1] Medimmune Inc, Gaithersburg, MD 20878 USA
[2] Medimmune Vaccines Inc, Gaithersburg, MD 20878 USA
关键词
antibiotics; influenza; cost;
D O I
10.1016/j.rmed.2004.03.021
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
To document the rate and cost of antibiotic prescribing for patients diagnosed only with influenza during US ambulatory care visits. Federal survey data for 1997-2001 were used to estimate outpatient trends for all patients and healthy people age 5-49 years. Cost estimates were based on Medicare payments and Red Book average wholesale prices in 2003. Antibiotic prescribing for influenza is widespread; 38% of visits led to an antibiotic prescription of which one-third were for broad spectrum antibiotics. Inappropriate antibiotics cost $18.5 million annually and may contribute to resistance. Increased vaccination rates and viral testing could reduce these trends. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1093 / 1101
页数:9
相关论文
共 32 条
[1]
[Anonymous], 1999, VITAL HLTH STAT SERI
[2]
Antibiotic prescribing by pediatricians for respiratory tract infection in children [J].
Arnold, SR ;
Allen, UD ;
Al-Zahrani, M ;
Tan, DHS ;
Wang, EEL .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :312-317
[3]
BERG JS, 1993, ANN PHARMACOTHER, V27, pS1
[4]
Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trial [J].
Bonner, AB ;
Monroe, KW ;
Talley, LI ;
Klasner, AE ;
Kimberlin, DW .
PEDIATRICS, 2003, 112 (02) :363-367
[5]
Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis [J].
Cantrell, R ;
Young, AF ;
Martin, BC .
CLINICAL THERAPEUTICS, 2002, 24 (01) :170-182
[6]
*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P800
[7]
Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1
[8]
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[9]
Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study [J].
ClavoSanchez, AJ ;
GironGonzalez, JA ;
LopezPrieto, D ;
CanuetoQuintero, J ;
SanchezPorto, A ;
VergaraCampos, A ;
MarinCasanova, P ;
CordobaDona, JA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1052-1059
[10]
COX F, 2000, COST ASSOCIATED TREA